QQQ   413.98 (-2.23%)
AAPL   165.02 (-1.21%)
MSFT   399.23 (-1.25%)
META   480.34 (-4.28%)
GOOGL   153.88 (-1.37%)
AMZN   174.01 (-2.91%)
TSLA   147.25 (-1.79%)
NVDA   769.64 (-9.10%)
AMD   145.73 (-6.03%)
NIO   3.81 (-4.75%)
BABA   69.14 (+0.38%)
T   16.50 (+1.04%)
F   12.10 (+0.33%)
MU   106.14 (-5.17%)
GE   148.20 (-3.10%)
CGC   7.98 (+1.92%)
DIS   112.19 (-0.21%)
AMC   3.18 (+8.90%)
PFE   25.99 (+2.36%)
PYPL   61.89 (-0.34%)
XOM   119.99 (+1.24%)
QQQ   413.98 (-2.23%)
AAPL   165.02 (-1.21%)
MSFT   399.23 (-1.25%)
META   480.34 (-4.28%)
GOOGL   153.88 (-1.37%)
AMZN   174.01 (-2.91%)
TSLA   147.25 (-1.79%)
NVDA   769.64 (-9.10%)
AMD   145.73 (-6.03%)
NIO   3.81 (-4.75%)
BABA   69.14 (+0.38%)
T   16.50 (+1.04%)
F   12.10 (+0.33%)
MU   106.14 (-5.17%)
GE   148.20 (-3.10%)
CGC   7.98 (+1.92%)
DIS   112.19 (-0.21%)
AMC   3.18 (+8.90%)
PFE   25.99 (+2.36%)
PYPL   61.89 (-0.34%)
XOM   119.99 (+1.24%)
QQQ   413.98 (-2.23%)
AAPL   165.02 (-1.21%)
MSFT   399.23 (-1.25%)
META   480.34 (-4.28%)
GOOGL   153.88 (-1.37%)
AMZN   174.01 (-2.91%)
TSLA   147.25 (-1.79%)
NVDA   769.64 (-9.10%)
AMD   145.73 (-6.03%)
NIO   3.81 (-4.75%)
BABA   69.14 (+0.38%)
T   16.50 (+1.04%)
F   12.10 (+0.33%)
MU   106.14 (-5.17%)
GE   148.20 (-3.10%)
CGC   7.98 (+1.92%)
DIS   112.19 (-0.21%)
AMC   3.18 (+8.90%)
PFE   25.99 (+2.36%)
PYPL   61.89 (-0.34%)
XOM   119.99 (+1.24%)
QQQ   413.98 (-2.23%)
AAPL   165.02 (-1.21%)
MSFT   399.23 (-1.25%)
META   480.34 (-4.28%)
GOOGL   153.88 (-1.37%)
AMZN   174.01 (-2.91%)
TSLA   147.25 (-1.79%)
NVDA   769.64 (-9.10%)
AMD   145.73 (-6.03%)
NIO   3.81 (-4.75%)
BABA   69.14 (+0.38%)
T   16.50 (+1.04%)
F   12.10 (+0.33%)
MU   106.14 (-5.17%)
GE   148.20 (-3.10%)
CGC   7.98 (+1.92%)
DIS   112.19 (-0.21%)
AMC   3.18 (+8.90%)
PFE   25.99 (+2.36%)
PYPL   61.89 (-0.34%)
XOM   119.99 (+1.24%)
Free Trial
OTCMKTS:KWBT

Kiwa Bio-Tech Products Group (KWBT) Stock Price, News & Analysis

→ The “Perfect Storm” for Gold (From Gold Safe Exchange) (Ad)
Free KWBT Stock Alerts
$0.0002
0.00 (0.00%)
(As of 09/25/2023)
Compare
Today's Range
$0.0002
▼
$0.0002
50-Day Range
N/A
52-Week Range
$0.0001
▼
$0.0010
Volume
2,600 shs
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Stock Analysis
Stock Analysis
KWBT stock logo

About Kiwa Bio-Tech Products Group Stock (OTCMKTS:KWBT)

Kiwa Bio-Tech Products Group Corporation, together with its subsidiaries, develops, manufactures, markets, and distributes bio-technological products for the agricultural market primarily in the People's Republic of China. It offers bacillus species and/or photosynthetic bacteria based biological organic, compound microbial, bio-water soluble, and microbial inoculum fertilizers. The company has a strategic cooperation agreements with the Beijing Zhongpin Agricultural Science and Technology Development Center; China Academy of Agricultural Science's Institute of Agricultural Resources & Regional Planning; and Institute of Agricultural Economy & Development, as well as Kiwa Bio-Tech (Yangling) Co. Ltd. Kiwa Bio-Tech Products Group Corporation was founded in 2002 and is headquartered in Yangling, China.

KWBT Stock Price History

KWBT Stock News Headlines

March 18, 2024 | markets.businessinsider.com
Dupharma Biotech forms R&D partnerships for new therapies
February 15, 2024 | realmoney.thestreet.com
One Small Biotech and Cannabis Are on My Mind as Market Laggards Fight Back
April 19, 2024 | Gold Safe Exchange (Ad)
The “Perfect Storm” for Gold
Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.
January 22, 2024 | bizjournals.com
Canada's largest biotech acquires Gaithersburg firm
January 9, 2024 | investing.com
Chenguang Biotech Group (300138)
January 5, 2024 | finanznachrichten.de
Shelly Group: Shelly Set to Launch Next Generation Products at CES 2024
January 5, 2024 | msn.com
US biotech company halts sales of DNA kits in Tibet, as lawmakers mull more export controls on China
July 1, 2023 | techrepublic.com
Top Products
April 19, 2024 | Gold Safe Exchange (Ad)
The “Perfect Storm” for Gold
Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.
June 28, 2023 | techrepublic.com
Support for these Microsoft enterprise products ends in 2023
June 13, 2023 | wsj.com
Shenzhen Agricultural Products Group Co. Ltd. A
May 15, 2023 | investing.com
Financial Products Group Co Ltd (7148)
March 10, 2023 | reuters.com
Cash is king in biotech M&A, but will clinical data be a saving grace?
October 3, 2022 | finance.yahoo.com
New Partners to Restructure KIWA
October 3, 2022 | finance.yahoo.com
New Partners to Restructure KIWA
September 24, 2022 | marketwatch.com
PHBI Pharmagreen Biotech Appoints Ethan Styles as Vice President of Product Research and Development
September 17, 2022 | benzinga.com
BioChain is officially a 10X Visium Certified Service Provider for spatial multiomics products and services
September 13, 2022 | benzinga.com
Kessler Topaz Meltzer & Check, LLP: Announces Securities Fraud Class Action Lawsuit Filed against Kiromic BioPharma, Inc.
September 13, 2022 | washingtonpost.com
Business Highlights: Twitter whistleblower, biotech push
September 8, 2022 | benzinga.com
The Gross Law Firm Announces Class Actions on Behalf of Shareholders of NIO, LTCH and ABT
August 17, 2022 | benzinga.com
Kasada Named One of Australia's Best Workplaces by Great Place to Work®
August 17, 2022 | msn.com
Needham Maintains Buy Rating for I-MAB: Here's What You Need To Know
August 15, 2022 | benzinga.com
Mitsubishi Tanabe Pharma America Announces Real-World Data Analysis of Survival with RADICAVA® (edaravone)
August 15, 2022 | yahoo.com
Black Bird Biotech Management Affirms Long-Term Commitment, Exchanges One-Third, over 120 Million, of Outstanding Common Shares for Preferred Shares
August 5, 2022 | benzinga.com
Kibo Releases Subscriptions Management To Help Retailers Boost Revenue and Customer Loyalty
August 5, 2022 | benzinga.com
Tebra Named on Top 100 Healthcare Technology Companies of 2022
August 1, 2022 | benzinga.com
BioIVT Announces Promotion of Dr. Richard Haigh to CEO
See More Headlines
Receive KWBT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Kiwa Bio-Tech Products Group and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/20/2018
Today
4/19/2024
Fiscal Year End
12/31/2024
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Basic Materials
Industry
Agricultural chemicals
Sub-Industry
N/A
Current Symbol
OTCMKTS:KWBT
CUSIP
N/A
CIK
1159275
Web
www.kiwabiotech.com
Phone
(909) 456-8828
Fax
626-626-7665
Employees
16
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
1.97
These 7 Stocks Will Be Magnificent in 2024 Cover
These 7 Stocks Will Be Magnificent in 2024

With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.

Get This Free Report

Key Executives

  • Ms. Ziqi Wang
    Chief Exec. Officer
  • Mr. Chaozhao Zhao
    Exec. Pres & GM of Mining Bus. Department
  • Mr. Sen Yang
    Chief Financial Officer
  • Mr. Boyu Liu
    Chief Operating Officer
  • Mr. Dadong Li
    Exec. VP
  • Mr. Mingzheng Bao
    CAO & CPO
  • Prof. Qi Wang (Age 57)
    Director

Key Competitors

View All Competitors

KWBT Stock Analysis - Frequently Asked Questions

How have KWBT shares performed in 2024?

Kiwa Bio-Tech Products Group's stock was trading at $0.0002 at the beginning of the year. Since then, KWBT shares have increased by 0.0% and is now trading at $0.0002.
View the best growth stocks for 2024 here.

How were Kiwa Bio-Tech Products Group's earnings last quarter?

Kiwa Bio-Tech Products Group Co. (OTCMKTS:KWBT) released its quarterly earnings results on Tuesday, November, 20th. The company reported $0.04 EPS for the quarter. The company earned $7.73 million during the quarter.

What other stocks do shareholders of Kiwa Bio-Tech Products Group own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Kiwa Bio-Tech Products Group investors own include Co-Diagnostics (CODX), BioRestorative Therapies (BRTX), FuelCell Energy (FCEL), iBio (IBIO), SANUWAVE Health (SNWV), Sierra Oncology (SRRA), Tonix Pharmaceuticals (TNXP), Aurora Cannabis (ACB) and Ascent Solar Technologies (ASTI).

How do I buy shares of Kiwa Bio-Tech Products Group?

Shares of KWBT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:KWBT) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners
The “Perfect Storm” for Gold
Gold Safe Exchange
The Best AI Stock to Own in the World Today is Trading for Just $25
Banyan Hill Publishing
Biden’s $374B Giveaway Into This Sector
DTI
He Is Giving Away Bitcoin
Crypto Swap Profits
Your Money is Not Safe
American Alternative
The #1 Crypto for 2024
InvestorPlace
SHOCKING Crypto Leak…
Crypto 101 Media
My biggest AI fear
Paradigm Press